Ross Muken
Stock Analyst at Evercore ISI Group
(2.62)
# 2,236
Out of 5,005 analysts
47
Total ratings
57.69%
Success rate
2.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $190 → $200 | $177.33 | +12.78% | 9 | Oct 3, 2025 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $67.03 | +4.43% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $193.89 | +23.78% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $141.64 | -8.22% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $46.80 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $154.46 | -56.62% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $102.12 | +144.81% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $543.32 | -59.51% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $14.67 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Oct 3, 2025
Maintains: Outperform
Price Target: $190 → $200
Current: $177.33
Upside: +12.78%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $67.03
Upside: +4.43%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $193.89
Upside: +23.78%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $141.64
Upside: -8.22%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $46.80
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $154.46
Upside: -56.62%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $102.12
Upside: +144.81%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $543.32
Upside: -59.51%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $14.67
Upside: -